118 related articles for article (PubMed ID: 23216562)
1. Atypical drug-induced hypersensitivity syndrome with human herpesvirus 6 reactivation due to calcium blockers.
Moriya M; Aihara M; Imai M; Ikezawa Y; Matsukura S; Kanbara T; Baba Y; Ikezawa Z
J Dermatol; 2013 Feb; 40(2):129-30. PubMed ID: 23216562
[No Abstract] [Full Text] [Related]
2. Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes.
Kamijima M; Wang H; Yamanoshita O; Ito Y; Xia L; Yanagiba Y; Chen C; Okamura A; Huang Z; Qiu X; Song X; Cai T; Liu L; Ge Y; Deng Y; Naito H; Yoshikawa T; Tohyama M; Li L; Huang H; Nakajima T
J Dermatol Sci; 2013 Dec; 72(3):218-24. PubMed ID: 23928230
[TBL] [Abstract][Full Text] [Related]
3. Azelnidipine. CS 905, Calblock, RS 9054.
Drugs R D; 2003; 4(2):122-5. PubMed ID: 12718569
[No Abstract] [Full Text] [Related]
4. Telaprevir-induced moderate cutaneous eruptions associated with HHV-6 reactivation.
Broccolo F; Ciccarese G; Agnoletti AF; Bruzzone L; Calamaro P; Zappacosta R; Oggioni M; Parodi A; Drago F
J Med Virol; 2015 Dec; 87(12):1985-6. PubMed ID: 25980458
[No Abstract] [Full Text] [Related]
5. Occupational trichloroethylene hypersensitivity syndrome with human herpesvirus-6 and cytomegalovirus reactivation.
Watanabe H; Tohyama M; Kamijima M; Nakajima T; Yoshida T; Hashimoto K; Iijima M
Dermatology; 2010 Aug; 221(1):17-22. PubMed ID: 20407216
[TBL] [Abstract][Full Text] [Related]
6. A case of toxic epidermal necrolysis induced by allopurinol with human herpesvirus-6 reactivation.
Watanabe Y; Matsukura S; Isoda Y; Morita A; Aihara M; Kambara T
Acta Derm Venereol; 2013 Nov; 93(6):731-2. PubMed ID: 23604033
[No Abstract] [Full Text] [Related]
7. Drug-induced hypersensitivity syndrome due to carbapenem antibiotics.
Goto M; Shimizu F; Takeo N; Okamoto O; Katagiri K; Ikewaki J; Ogata M; Kadota J; Fujiwara S
J Dermatol; 2010 Apr; 37(4):374-7. PubMed ID: 20507410
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS).
Ogawa K; Morito H; Hasegawa A; Miyagawa F; Kobayashi N; Watanabe H; Sueki H; Tohyama M; Hashimoto K; Kano Y; Shiohara T; Ito K; Fujita H; Aihara M; Asada H
Br J Dermatol; 2014 Aug; 171(2):425-7. PubMed ID: 24601914
[No Abstract] [Full Text] [Related]
9. Latent Hepatitis Virus Reactivation Due to Drug Reaction: DRESSed to Kill?
Alexanian D; Birg A; Volpicelli N; Glass J; McCarthy D
Dig Dis Sci; 2018 May; 63(5):1143-1147. PubMed ID: 29594978
[No Abstract] [Full Text] [Related]
10. Drug-induced hypersensitivity syndrome with human herpesvirus-6 reactivation.
Riyaz N; Sarita S; Arunkumar G; Sabeena S; Manikoth N; Sivakumar CP
Indian J Dermatol Venereol Leprol; 2012; 78(2):175-7. PubMed ID: 22421649
[TBL] [Abstract][Full Text] [Related]
11. Facial paralysis associated with drug reaction with eosinophilia and systemic symptoms (DRESS) with oxcarbazepine and reactivation of human herpesvirus 6 (HHV-6).
Kluger N; Descamps V; Lappalainen K; Roivainen R
Int J Dermatol; 2020 Apr; 59(4):e114-e115. PubMed ID: 31840232
[No Abstract] [Full Text] [Related]
12. TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS).
Uno H; Kabashima K; Tohyama M; Watanabe T; Hashimoto K; Iijima M; Sueki H; Watanabe H
J Dermatol Sci; 2014 May; 74(2):177-9. PubMed ID: 24517870
[No Abstract] [Full Text] [Related]
13. Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7.
Yagami A; Yoshikawa T; Asano Y; Koie S; Shiohara T; Matsunaga K
Dermatology; 2006; 213(4):341-4. PubMed ID: 17135743
[TBL] [Abstract][Full Text] [Related]
14. Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome.
Nakamura-Nishimura Y; Miyagawa F; Miyashita K; Ommori R; Azukizawa H; Asada H
Br J Dermatol; 2018 Jun; 178(6):1430-1432. PubMed ID: 29150836
[No Abstract] [Full Text] [Related]
15. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
[TBL] [Abstract][Full Text] [Related]
16. Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation.
Balci DD; Peker E; Duran N; Dogramaci CA
Cutan Ocul Toxicol; 2009; 28(1):45-7. PubMed ID: 19514926
[TBL] [Abstract][Full Text] [Related]
17. Case of drug-induced hypersensitivity syndrome with multiple skin ulcers caused by herpes simplex virus reactivation.
Morita M; Komine M; Takatsuka Y; Hosoda S; Onda H; Maekawa T; Murata S; Ohtsuki M
J Dermatol; 2013 Feb; 40(2):132-4. PubMed ID: 23083318
[No Abstract] [Full Text] [Related]
18. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection.
Chiou CC; Chung WH; Hung SI; Yang LC; Hong HS
J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S14-7. PubMed ID: 16427984
[TBL] [Abstract][Full Text] [Related]
19. [Case report; A case of fulminant type 1 diabetes associated with drug-induced hypersensitivity syndrome].
Ochiai H; Okazaki H; Ogata H; Suga H; Tsunekawa S; Oiso Y
Nihon Naika Gakkai Zasshi; 2014 May; 103(5):1183-6. PubMed ID: 25026790
[No Abstract] [Full Text] [Related]
20. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction.
Aihara Y; Ito SI; Kobayashi Y; Yamakawa Y; Aihara M; Yokota S
Br J Dermatol; 2003 Jul; 149(1):165-9. PubMed ID: 12890212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
